Basel, Switzerland

Nadege Graveleau

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hesingue, FR (2014)
  • Basel, CH (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nadege Graveleau: Innovator in Pharmaceutical Chemistry

Introduction

Nadege Graveleau is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, her work focuses on innovative solutions for treating diseases mediated by specific enzyme activities.

Latest Patents

Nadege's latest patents include the development of substituted tetrahydro-pyrido-pyrimidine derivatives. These compounds are designed to target disorders or diseases that are influenced by the activity of PI3K enzymes. The detailed formula and specifications of these derivatives are outlined in her patent documentation, showcasing her expertise in medicinal chemistry.

Career Highlights

Nadege Graveleau is currently associated with Novartis AG, a leading global healthcare company. Her role involves extensive research and development, contributing to the advancement of therapeutic solutions. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Throughout her career, Nadege has collaborated with esteemed colleagues, including Nigel Graham Cooke and Paulo Antonio Fernandes Gomes Dos Santos. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Nadege Graveleau's contributions to pharmaceutical chemistry exemplify her commitment to innovation and excellence. Her patents reflect her dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…